Literature DB >> 11724752

Orexin A and B evoke noradrenaline release from rat cerebrocortical slices.

K Hirota1, T Kushikata, M Kudo, T Kudo, D G Lambert, A Matsuki.   

Abstract

1. Orexin A and B, recently identified in the rat hypothalamus are endogenous neuropeptide agonists for the G-protein coupled orexin-1 (OX1) and orexin-2 (OX2) receptors. 2. In the present study, we have examined the effects of orexin A, B and raised extracellular K(+) on noradrenaline release from the rat cerebrocortical slice. We have compared this with other sleep-wake-related (excitatory) neurotransmitters; dopamine, glutamate, serotonin and histamine. 3. Neurotransmitter release studies were performed in rat cerebrocortical slices incubated in modified Krebs buffer (with and without Ca(2+)+EGTA 1 mM) with various concentrations of orexin A, B and K(+) for various times. 4. Orexin A and B-evoked (10(-7) M) noradrenaline release was time-dependent reaching a maximum some 10 min after stimulation. K(+) (40 mM) evoked release was also time dependent but reached a maximum after 6 min. Orexin A, B and K(+) stimulation of release was concentration dependent with pEC(50) and E(max) (% of basal) values of 8.74+/-0.32 (1.8 nM) and 263+/-14% and 8.61+/-0.38 (2.4 nM) and 173+/-7% and 1.43+/-0.02 (37 mM) and 1430+/-70%, respectively. Orexin-evoked release was partially extracellular Ca(2+) dependent. 5. Of the other transmitters studied there was a weak orexin A and B stimulation of glutamate release. In contrast K(+) evoked dopamine, glutamate, histamine and serotonin release with pEC(50) and E(max) (% of basal) values of 1.47+/-0.05 (34 mM) and 3430+/-410%, 1.38+/-0.04 (42 mM) and 1240+/-50%, 1.47+/-0.02 (34 mM) and 480+/-10% and 1.40+/-0.05 (40 mM) and 560+/-60% respectively. 6. We conclude that the neuropeptides orexin A and B evoke noradrenaline release from rat cerebrocortical slices.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724752      PMCID: PMC1573092          DOI: 10.1038/sj.bjp.0704409

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Cardiovascular regulatory actions of the hypocretins in brain.

Authors:  W K Samson; B Gosnell; J K Chang; Z T Resch; T C Murphy
Journal:  Brain Res       Date:  1999-06-12       Impact factor: 3.252

2.  Acetylcholine and glutamate release during sleep-wakefulness in the pedunculopontine tegmental nucleus and norepinephrine changes regulated by nitric oxide.

Authors:  T Kodama; Y Honda
Journal:  Psychiatry Clin Neurosci       Date:  1999-04       Impact factor: 5.188

3.  The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.

Authors:  L Lin; J Faraco; R Li; H Kadotani; W Rogers; X Lin; X Qiu; P J de Jong; S Nishino; E Mignot
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

4.  Distribution of orexin receptor mRNA in the rat brain.

Authors:  P Trivedi; H Yu; D J MacNeil; L H Van der Ploeg; X M Guan
Journal:  FEBS Lett       Date:  1998-10-30       Impact factor: 4.124

5.  Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems.

Authors:  Y Date; Y Ueta; H Yamashita; H Yamaguchi; S Matsukura; K Kangawa; T Sakurai; M Yanagisawa; M Nakazato
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

6.  Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR.

Authors:  D Smart; J C Jerman; S J Brough; S L Rushton; P R Murdock; F Jewitt; N A Elshourbagy; C E Ellis; D N Middlemiss; F Brown
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

7.  In vivo microdialysis measures of extracellular serotonin in the rat hippocampus during sleep-wakefulness.

Authors:  S P Park; F Lopez-Rodriguez; C L Wilson; N Maidment; Y Matsumoto; J Engel
Journal:  Brain Res       Date:  1999-07-03       Impact factor: 3.252

8.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

Authors:  J J Hagan; R A Leslie; S Patel; M L Evans; T A Wattam; S Holmes; C D Benham; S G Taylor; C Routledge; P Hemmati; R P Munton; T E Ashmeade; A S Shah; J P Hatcher; P D Hatcher; D N Jones; M I Smith; D C Piper; A J Hunter; R A Porter; N Upton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

9.  Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

Authors:  R M Chemelli; J T Willie; C M Sinton; J K Elmquist; T Scammell; C Lee; J A Richardson; S C Williams; Y Xiong; Y Kisanuki; T E Fitch; M Nakazato; R E Hammer; C B Saper; M Yanagisawa
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

10.  Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin.

Authors:  A N van den Pol; X B Gao; K Obrietan; T S Kilduff; A B Belousov
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

View more
  9 in total

Review 1.  Energy expenditure: role of orexin.

Authors:  Jennifer A Teske; Vijayakumar Mavanji
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

Review 2.  Neuropeptides controlling energy balance: orexins and neuromedins.

Authors:  Joshua P Nixon; Catherine M Kotz; Colleen M Novak; Charles J Billington; Jennifer A Teske
Journal:  Handb Exp Pharmacol       Date:  2012

Review 3.  Tobacco dependence, the insular cortex and the hypocretin connection.

Authors:  Paul J Kenny
Journal:  Pharmacol Biochem Behav       Date:  2010-09-09       Impact factor: 3.533

4.  Effects of orexin-A on propofol anesthesia in rats.

Authors:  Tetsuro Shirasaka; Tetsu Yonaha; Shin Onizuka; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2010-12-10       Impact factor: 2.078

5.  Role of orexin-A in the ventrolateral preoptic area on components of total energy expenditure.

Authors:  J E Coborn; D P DePorter; V Mavanji; C M Sinton; C M Kotz; C J Billington; J A Teske
Journal:  Int J Obes (Lond)       Date:  2017-04-10       Impact factor: 5.095

6.  Delayed orexin signaling consolidates wakefulness and sleep: physiology and modeling.

Authors:  C G Diniz Behn; N Kopell; E N Brown; T Mochizuki; T E Scammell
Journal:  J Neurophysiol       Date:  2008-04-16       Impact factor: 2.714

7.  Hypocretin/Orexin Peptides Alter Spike Encoding by Serotonergic Dorsal Raphe Neurons through Two Distinct Mechanisms That Increase the Late Afterhyperpolarization.

Authors:  Masaru Ishibashi; Iryna Gumenchuk; Kenichi Miyazaki; Takafumi Inoue; William N Ross; Christopher S Leonard
Journal:  J Neurosci       Date:  2016-09-28       Impact factor: 6.167

8.  Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats.

Authors:  Jemma K Richards; Jeffrey A Simms; Pia Steensland; Sharif A Taha; Stephanie L Borgland; Antonello Bonci; Selena E Bartlett
Journal:  Psychopharmacology (Berl)       Date:  2008-05-10       Impact factor: 4.530

9.  Differential roles of orexin receptors in the regulation of sleep/wakefulness.

Authors:  Michihiro Mieda; Natsuko Tsujino; Takeshi Sakurai
Journal:  Front Endocrinol (Lausanne)       Date:  2013-05-16       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.